Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer

Abstract

Our findings demonstrate a protective role for IL-37 in lung cancer development, possibly through inhibiting tumor angiogenesis. IL-37 could serve as a promising therapeutic target for NSCLC.